100 related articles for article (PubMed ID: 6592097)
1. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
McGivern DV; Basran GS
Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man.
Archer CB; Frohlich W; Page CW; Paul W; Morley J; MacDonald DM
Prostaglandins; 1984 Mar; 27(3):495-501. PubMed ID: 6203139
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
Brunelleschi S; Haye-Legrand I; Labat C; Norel X; Benveniste J; Brink C
J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
Morley J; Page CP; Paul W
Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
Archer CB; Page CP; Paul W; Morley J; MacDonald DM
Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
[TBL] [Abstract][Full Text] [Related]
7. Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma.
Basran GS; Morley J; Paul W; Turner-Warwick M
Lancet; 1982 Apr; 1(8278):935-7. PubMed ID: 6122773
[TBL] [Abstract][Full Text] [Related]
8. Delayed-onset synergism between leukotriene B4 and prostaglandin E2 in human skin.
Archer CB; Page CP; Juhlin L; Morley J; MacDonald DM
Prostaglandins; 1987 Jun; 33(6):799-805. PubMed ID: 2823313
[TBL] [Abstract][Full Text] [Related]
9. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
Steel G; Wallace JL; Whittle BJ
Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
11. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages.
Bachelet M; Adolfs MJ; Masliah J; Bereziat G; Vargaftig BB; Bonta IL
Eur J Pharmacol; 1988 Apr; 149(1-2):73-8. PubMed ID: 2840303
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P
Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773
[TBL] [Abstract][Full Text] [Related]
13. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
14. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.
Archer CB; MacDonald DM; Morley J; Page CP; Paul W; Sanjar S
Br J Pharmacol; 1985 May; 85(1):109-13. PubMed ID: 2862936
[TBL] [Abstract][Full Text] [Related]
15. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin.
Fjellner B; Hägermark O
Acta Derm Venereol; 1985; 65(5):409-12. PubMed ID: 2416164
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor and the responses of rat isolated stomach strip to prostaglandin E2.
Izzo AA; Mascolo N; Autore G; Capasso F
J Pharm Pharmacol; 1993 Aug; 45(8):761-2. PubMed ID: 7901378
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory effects of platelet activating factor (PAF) in equine skin.
Foster AP; Cunningham FM; Lees P
Equine Vet J; 1992 May; 24(3):208-14. PubMed ID: 1606934
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Brain SD; Williams TJ
Br J Pharmacol; 1985 Dec; 86(4):855-60. PubMed ID: 2416378
[TBL] [Abstract][Full Text] [Related]
19. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
Becker K; Förster W
Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis.
Ibbotson GC; Wallace JL
Prostaglandins; 1989 Feb; 37(2):237-50. PubMed ID: 2727308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
